FDA Cosmetics Stakeholders Meeting To Review International Harmonization
This article was originally published in The Rose Sheet
Executive Summary
International harmonization is one of five topics scheduled to be discussed at a Jan. 22 FDA public meeting in Washington, D.C. During the gathering, the Office of Cosmetics & Colors will solicit comments on priorities and strategies for the agency's cosmetics regulatory program.